Skip to Content
Merck
  • A spot test for determination of residual TBA levels in 18F-radiotracers for human use using Dragendorff reagent.

A spot test for determination of residual TBA levels in 18F-radiotracers for human use using Dragendorff reagent.

Analytical methods : advancing methods and applications (2020-10-02)
Sean S Tanzey, Andrew V Mossine, Alexandra R Sowa, Jovany Torres, Allen F Brooks, Melanie S Sanford, Peter J H Scott
ABSTRACT

When utilizing [18F]tetrabutylammonium fluoride ([18F]TBAF) in the synthesis of 18F-labeled radiotracers for clinical positron emission tomography (PET) imaging, it is necessary to confirm that residual TBA levels in formulated doses do not exceed established specifications (≤2.6 mg per patient dose). Historically this has been accomplished using HPLC, but this is time consuming for short-lived PET radiotracers and limited by the need for expensive equipment. This motivated us to introduce a TLC spot test for determining residual TBA, and we have developed a new method which employs the Dragendorff reagent. Herein we report details of the TLC method and use it to quantify residual TBA in different formulations of 6-[18F]fluoro-DOPA.

MATERIALS
Product Number
Brand
Product Description

Supelco
Dragendorff reagent, for TLC derivatization
Sigma-Aldrich
Tetraethylammonium bicarbonate, ≥95.0% (T)